2018

• Perforin inhibition protects from lethal endothelial damage during fulminant viral hepatitis.

  Nature Communications

  11/15/2018
  

• The soluble guanylate cyclase stimulator riociguat reduces fibrogenesis and portal pressure in cirrhotic rats

  Scientific Reports

  6/19/2018
  

• Managing portal hypertension in patients with liver cirrhosis

  F1000Research

  5/2/2018
  

• Controlled attenuation parameter and alcoholic hepatic steatosis: Diagnostic accuracy and role of alcohol detoxification

  Journal of Hepatology

  5/1/2018
  

• Accuracy of the Enhanced Liver Fibrosis Test vs FibroTest, Elastography, and Indirect Markers in Detection of Advanced Fibrosis in Patients With Alcoholic Liver Disease

  Gastroenterology

  4/2/2018
  

• Antifibrotic and molecular aspects of rifaximin in alcoholic liver disease: study protocol for a randomized controlled trial

  Trials

  2/26/2018
  

• Evolution of nodule stiffness might predict response to local ablative therapy: A series of patients with hepatocellular carcinoma.

  PLoS One

  2/14/2018
  

• Acute decompensation boosts hepatic collagen type III deposition and deteriorates experimental and human cirrhosis

  Hepatology Communications

  1/18/2018